Agenda EURLSSG-Meeting
Friday 9th Dec. 2011 8:30 - 17:00 h
Epidemiological and experimental data
Chairpersons:
Marco Zucconi, Milan, Italy
Karin Stiasny-Kolster, Marburg, Germany
Results from prospective cohort studies on RLS, with a focus on [ABSTRACT]
- RLS and mortality
- Incidence and risk factors of RLS
- Change in RLS symptoms and/or severity over time
Klaus Berger, Münster, Germany
RLS in a Georgian individuals with and without epilepsy – A questionnaire study [ABSTRACT]
Lia Maisuradze and Sofia Kasradze, Tbilisi, Georgia
Restless legs syndrome and epilepsy
Samson Khachatryan, Yerevan, Armenia
RLS severity symptoms in relation to environmental and habitual conditions - the Mediterranean example. Acronym: HappyFeet [ABSTRACT]
Georgios Hadjigeorgiou, Larissa, Greece
The A11 diencephalospinal pathway in non human primates is not dopaminergic
Imad Ghorayeb, Bordeaux, France
Skeletal muscle morphology in patients with RLS [ABSTRACT]
Britta Wåhlin-Larsson, Örebro, Sweden
Effects of transcutaneous spinal direct current stimulation in patients with idiopathic RLS [ABSTRACT]
Cornelius Bachmann, Göttingen, Germany
Clinical Findings I
Chairpersons:
Magdolna Hornyak, Freiburg, Germany
Georgios Hadjigeorgiou, Larissa, Greece
Validation of a new interview method for the diagnosis of RLS augmentation (RLS-AUDI)
Heike Benes, Schwerin, Germany
Validation study of a patient-reported IRLS
Ralf Kohnen, Nuremberg, Germany
Experience with the Johns Hopkins Telephone Diagnostic Interview
Thomas Mitterling, Innsbruck, Austria
Occurence of periodic limb movements in primary insomnia
Michaela Sebert, Berlin, Germany
Periodic limb movements in sleep as a potential cardiovascular risk factor in hemodialysis patients: association to cardiac structure and function [ABSTRACT]
Christoforos Giannaki, Larissa, Greece
Subjective and objective measures of excessive daytime sleepiness in RLS
Hildegard Hidalgo, Zürich, Switzerland
- Discussion -
Clinical Findings II
Chairpersons:
Olli Polo, Turku, Finland
Rosalia Silvestri, Messina, Italy
Searching for silent strokes in magnetic resonance imaging of patients with RLS and Controls [ABSTRACT]
Raffaele Ferri, Troina, Italy
Iron and glutamate in RLS
Richard Allen, Baltimore, USA
Restless legs syndrome (RLS) in children: presenting symptoms [ABSTRACT]
Al de Weerd, Zwolle, Netherlands
-Discussion -
Treatment Options:
Chairpersons:
Diego Garcia Borreguero, Madrid, Spain
Claudia Trenkwalder, Kassel, Germany
Change of psychosocial impairment during treatment of RLS: what can we learn from randomized controlled trials?
Hanna Scholz, Freiburg, Germany
Time course of response to intravenous iron in RLS
Magdolna Hornyak, Freiburg, Germany
Peripheral nerve compressions in the lower extremities aggravating RLS Severity - a new therapeutical option for selected patients [ABSTRACT]
Martin Raghunath, Munich/Frankfurt, Germany
Assessing the efficacy and safety of botulinum toxin type A in patients with RLS (unpublished data)
Imad Ghorayeb, Bordeaux, France
Overview on non-pharmacological interventions in RLS
Giorgos Sakkas, Larissa, Greece
Current Status of RLS in Finland
Markku Partinen, Espoo, Finland
State-of-the-art and other news
Chairpersons:
Juliane Winkelmann, Munich, Germany
Birgit Högl, Innsbruck, Austria
RLS name change: current plans - A report from the IRLSSG meeting September 2011 in Quebec
Diego Garcia Borreguero, Madrid, Spain
Update on genetics
Juliane Winkelmann, Munich, Germany
A unifying model of RLS: 2011 update
Olli Polo, Tampere, Finland
Development of the brain bank
Lilo Habersack, Munich, Germany
Agenda Workshop
Saturday 10th Dec. 2011 9:00 - 13:15 h
OBJECTIVE VS SUBJECTIVE MEASURES FOR
DIAGNOSIS AND TREATMENT OF RLS
Chairpersons: Marco Zucconi, Italy and Raffaele Ferri, Italy
Objective
PLMS as a tool for the diagnosis of RLS and the evaluation of drug effects
Mauro Manconi, Switzerland
Do PLMW and SIT improve the specificity of PLMS for diagnosis and treatment effect evaluation in RLS?
Diego Garcia-Borreguero, Spain and Marco Zucconi, Italy
Do sleep macro- and microstructure add something to the diagnosis and treatment effect evaluation in RLS?
Raffaele Ferri, Italy
Is there a role for the pharmacologic test?
Karin Stiasny-Kolster, Germany
Role and limits of actigraphy?
Richard Allen, USA and Birgit Högl, Austria
Which is the role of peripheral nerve investigation for RLS diagnosis?
Cornelius Bachmann, Germany
Subjective
RLS Diagnostic Index vs IRLSSG criteria and other questionnaires for the diagnosis of RLS
Heike Benes, Germany
IRLS, RLS-6 and other severity scales to measure the effect of treatment for RLS
Ralf Kohnen, Germany
Quality of life (QoL) and depression/anxiety symptom measures for the assessment of treatment in RLS
Jan Wesström, Sweden
Other subjective items/scales to test RLS complications or side effects (augmentation, impulsive control disorders, etc)
Rosalia Silvestri, Italy
Final Discussion